5266 articles
Michelle Henry of Weill Cornell Medical College, New York, and a paid spokesperson for Aclaris Therapeutics, talks about seborrheic keratoses (or S-KS f...
Cybrexa is a privately-held biotechnology company dedicated to developing an entirely new class of small molecule DNA repair inhibitors and DNA damaging...
David Heller, a vendor of health information technology, discusses the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) changes coming in 2019.
Adi Diab, M.D., Lead Trial Investigator, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Canc...
Brian Mech, Ph.D discusses eSight - the creators of electronic glasses that enable the legally blind to actually see again.
Larry Hirsch shares his personal story of having Type 1 Diabetes and how it motivated him to help others, offers expert advice to those who have diabete...
Jennifer Flynn, a representative from Nurses Service Organization (NSO), discusses sexual inappropriate behavior against nurses and other caregivers by ...
Dr. Philip Salem, former White House Healthcare Advisor for Presidents George Bush and Bill Clinton, discusses his upcoming book, "Defeating Cancer: Kno
Ronald van Vollenhoven, M.D., Ph.D., talks about new, positive, one-year results from a continued Phase 2 study investigating STELARA® (ustekinumab) in...
Bruce Sands from Mount Sinai discusses his presentation of the new pivotal Phase 3 data at the American College of Gastroenterology (ACG) Annual Scienti...